Zoetis price target lowered to $130 from $136 at UBS

UBS lowered the firm’s price target on Zoetis (ZTS) to $130 from $136 and keeps a Neutral rating on the shares. The Q1 earnings outlook is cautious amid softer macro conditions and declining vet visit trends, though U.S. pet results are expected to hold up, the analyst tells investors in a research note. For Zoetis, low valuation limits downside, but uncertainty around reporting changes and upcoming competitive launches continues to cloud estimates despite generally achievable segment expectations, the firm says.